These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4269 related articles for article (PubMed ID: 6362841)

  • 1. Dimethyl triazeno imidazole carboxamide and combination therapy for melanoma. IV. Late results after complete response to chemotherapy (Central Oncology Group protocols 7130, 7131, and 7131A).
    Hill GJ; Krementz ET; Hill HZ
    Cancer; 1984 Mar; 53(6):1299-305. PubMed ID: 6362841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanoma.
    Van Dyk JJ; Falkson G
    Med Pediatr Oncol; 1975; 1(2):107-11. PubMed ID: 1228411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete remission of brain metastases in three patients with stage IV melanoma treated with BOLD and G-CSF.
    Bottoni U; Bonaccorsi P; Devirgiliis V; Panasiti V; Borroni RG; Trasimeni G; Clerico R; Calvieri S
    Jpn J Clin Oncol; 2005 Sep; 35(9):507-13. PubMed ID: 16120623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of dacarbazine versus bleomycin, vincristine, lomustine and dacarbazine (BOLD) chemotherapy combined with natural or recombinant interferon-alpha in patients with advanced melanoma.
    Vuoristo MS; Hahka-Kemppinen M; Parvinen LM; Pyrhönen S; Seppä H; Korpela M; Kellokumpu-Lehtinen P
    Melanoma Res; 2005 Aug; 15(4):291-6. PubMed ID: 16034308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy of malignant melanoma. A pilot study.
    Hansson J; Ringborg U; Lagerlöf B; Strander H
    Am J Clin Oncol; 1985 Feb; 8(1):47-50. PubMed ID: 3993625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy (dacarbazine, carmustine, cisplastin, and tamoxifen) in advanced melanoma.
    Tan EH; Ang PT
    Singapore Med J; 1996 Apr; 37(2):165-7. PubMed ID: 8942255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination chemotherapy of disseminated skin melanoma with nitrosomethylurea].
    Perevodchikova NJ; Moros LW; Kogonia LM
    Arch Geschwulstforsch; 1986; 56(4):273-81. PubMed ID: 3530176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleomycin, vincristine, lomustine, and DTIC chemotherapy for metastatic melanoma.
    York RM; Foltz AT
    Cancer; 1988 Jun; 61(11):2183-6. PubMed ID: 2452681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ineffectiveness of adjuvant chemotherapy using DTIC and cyclophosphamide in patients with resectable metastatic melanoma.
    Balch CM; Murray D; Presant C; Bartolucci AA
    Surgery; 1984 Apr; 95(4):454-9. PubMed ID: 6369594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete responses and survival after polychemotherapy plus interferon-alpha for patients with metastatic melanoma.
    Vuoristo MS
    Melanoma Res; 1996 Aug; 6(4):331-6. PubMed ID: 8873054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.
    Serrone L; Zeuli M; Sega FM; Cognetti F
    J Exp Clin Cancer Res; 2000 Mar; 19(1):21-34. PubMed ID: 10840932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A promising interferon plus four-drug chemotherapy regimen for metastatic melanoma.
    Pyrhönen S; Hahka-Kemppinen M; Muhonen T
    J Clin Oncol; 1992 Dec; 10(12):1919-26. PubMed ID: 1280673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy of disseminated melanoma with bleomycin, vincristine, CCNU, and DTIC (BOLD regimen). The Prudente Foundation Melanoma Study Group.
    Cancer; 1989 May; 63(9):1676-80. PubMed ID: 2467736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the efficacy of imidazole-carboxamide and of a combination of nitrosomethylurea, vincristine and dactinomycin in disseminated melanoma].
    Kogoniia LM; Moroz LV; Perevodchikova NI; Platinskiĭ LV; Borisov AI
    Vopr Onkol; 1981; 27(4):16-21. PubMed ID: 7015692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of metastasising melanoma with a combination of cytostatic agents (author's transl)].
    Kleeberg UR; Schreml W
    Dtsch Med Wochenschr; 1976 Jun; 101(23):890-4. PubMed ID: 1269431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Marked regression of melanoma metastases under combined chemotherapy].
    Klemm-Mayer H; Rasokat H; Wagner G
    Z Hautkr; 1984 Apr; 59(7):443-5. PubMed ID: 6730608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy plus levamisole in the treatment of disseminated malignant melanoma. A Southwest Oncology Group study.
    Costanzi JJ; Fletcher WS; Balcerzak SP; Taylor S; Eyre HJ; O'Bryan RM; Al-Sarraf M; Frank J
    Cancer; 1984 Feb; 53(4):833-6. PubMed ID: 6362830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does complete response to systemic therapy in patients with stage IV melanoma translate into long-term survival?
    Bedikian AY; Johnson MM; Warneke CL; Papadopoulos NE; Kim KB; Hwu WJ; McIntyre S; Rohlfs M; Homsi J; Hwu P
    Melanoma Res; 2011 Feb; 21(1):84-90. PubMed ID: 21102360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective evaluation of a triple-drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanoma.
    Legha SS; Ring S; Papadopoulos N; Plager C; Chawla S; Benjamin R
    Cancer; 1989 Nov; 64(10):2024-9. PubMed ID: 2804890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of therapy on the antioxidant status in patients with melanoma.
    Gadjeva V; Dimov A; Georgieva N
    J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 214.